Dan KlassPrincipal Scientist, Oncology Assay Development, Roche Sequencing Solutions
Dan earned his PhD in Biochemistry from Stanford University where he focused on developing new methods utilizing the latest in proteomic and genomic technologies in Pat Brown’s lab. As a postdoctoral scholar in the Oncology department at Stanford, he co-invented the CAPP-Seq technology for ctDNA NGS, and he has been working from within the Oncology Assay Development team to bring the technology to market ever since CAPP Medical was acquired by Roche Sequencing Solutions. He is currently designing the next generation of oncology assays and evaluating the potential oncology applications of new technologies. |
Toshihiro TanakaProfessor, Tokyo Medical and Dental University (TMDU)
Toshihiro Tanaka, MD, PhD is a geneticist and cardiologist, who first in the world identified genetic variants that are associated with a common disease, myocardial infarction, through genome-wide association study (GWAS). He also contributed to The International HapMap Project and Japanese Millennium Genome Project, and recently, the group led by him published two papers in Nature Genetics describing genes associated with atrial fibrillation. Genetics of long QT syndrome has been one of his works before he received PhD on " Genetic linkage analyses of Romano-Ward syndrome (RWS) in 13 Japanese families". His research interests include genetic analyses of cardiovascular diseases and social implementation/clinical application of genetic information. |
